Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H.; Epplen, J.T.; Schöls, L. and O. Rieß: Ala30Pro missense mutation in the alpha-synuclein gene causes autosomal dominant Parkinson's disease. Nature Genet 18, (1998), 106-108. |
Berg, D.; Holzmann, C. and O. Riess: 14-3-3 proteins in brain and in neurological diseases. Nat Rev Neurosci 4, (2003), 752-762. |
Bichelmeier, U.; Schmidt, T.; Hübener, J.; Boy, J.; Wilbertz, J.; Wolburg, H.; Laccone, F. and O. Riess: Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: In vivo evidence. J Neurosci 27, (2007), 7418-28. |
Metzger, S., Rong, J., Nguyen, H.P., Cape, A., Tomiuk, J., Soehn, A., Propping, P., Freudenberg-Hua, Y., Freudenberg, J., Tong, L., Li, S.H., Li, X.-J. and O. Riess: Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease. Hum Mol Genet 17, (2008), 1137-46. |
Nuber, S.; Petrasch-Parwez, E.; Winner, B.; Winkler, J.; von Hörsten, S.; Schmidt, T.; Boy, J.; Kuhn, M.; Nguyen, H.P.; Teismann, P.; Schulz, J.B.; Neumann, M.; Pichler, B.J.; Reischl, G.; Holzmann, C.; Schmitt, I.; Bornemann, A.; Kuhn, W.; Zimmermann, F.; Servadio, A. and Riess, O.: Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease. J Neurosci 28, (2008), 2471-84. |